Telezon (ASX:TLZ) signs production pact with GEMU

Telezon (ASX:TLZ) signs production pact with GEMU

Medical technology company Telezon (ASX:TLZ) has announced it has signed an agreement with surgical device and accessory developer GEMU with the aim of commercialising a new needle device.

The non-binding agreement will see the parties work towards commercialisation of the SSB draw-up needle.

But moving forward will depend on the outcome of moulding trials at GEMU's Swiss facilities. If the trials prove successful, the parties will then orchestrate a small volume pilot production run.

Join the CIO Australia group on LinkedIn. The group is open to CIOs, IT Directors, COOs, CTOs and senior IT managers.

Join the newsletter!


Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

Tags productionHealthcarebusiness dealsTelezon

Show Comments